Archive for March, 2018

  • aside

    Isofol Medical has selected arfolitixorin-dose for the phase III pivotal study ISO-CC-007

    The selected dose for the drug candidate arfolitixorin of 120 mg/m2, (approximately 200 mg for an adult male) is based…

    by